Is a complete VYGR research report available?

No complete published report is available for Voyager Therapeutics, Inc. (VYGR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Voyager Therapeutics, Inc. (VYGR)

NASDAQ: VYGR · USD

$3.10

+0.01 (+0.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-26 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first VYGR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	187.3M
Revenue (ttm)	36.5M
Net income (ttm)	-116.6M
EPS (ttm)	-$1.98
Shares out	60.4M
Volume	483,013
Beta	1.27
Price target	$14.9	+380.3%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 36.5M
Net income (ttm): -116.6M
EPS (ttm): -$1.98
Market cap: 187.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All VYGR indicators

Market & fundamental data

Available fields

207

Groups with data

Currency

USD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001640266
Company name	Voyager Therapeutics, Inc.
Country	United States
Country code	US
Cusip	92915B106
Employees	141
Employees Change	-31%
Employees Change Percent	-18.02
Enterprise value	$50.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2015-11-11
Isin	US92915B1061
Last refreshed	2026-07-26
Market cap	$187.3M
Market cap category	Micro-Cap
Price	$3.1
Price currency	USD
Rev Per Employee	258,822.7x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2836
Symbol	VYGR
Website	https://www.voyagertherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-62.27%
EV Sales Forward	1.11x
EV/Sales	1.38x
FCF yield	-69.37%
P/B ratio	1.08x
P/S ratio	5.13x
PS Forward	4.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-349.16%
EBITDA Margin	-338.26%
Gross margin	-243.48%
Gross Profit	$-88.9M
Net Income	$-116.6M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-319.27%
Profit Per Employee	$-827,213
ROA	-27.05
Roa5y	-8.99
ROCE	-63.12
ROE	-52.26
Roe5y	-20.05
ROIC	-240.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-13.91%
Cagr1y	-5.49%
Cagr3y	-30.71%
Cagr5y	-0.13%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	-45.5x
Revenue Growth Q	-59.94x
Revenue Growth Years	0x
Revenue Growth3 Y	-42.38x
Revenue Growth5 Y	-25.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.13
Assets	$219.3M
Cash	$141.5M
Current Assets	$147M
Current Liabilities	$17.5M
Debt	$34.6M
Debt Equity	$0.2
Equity	$173.7M
Liabilities	$45.7M
Long Term Assets	$72.3M
Long Term Liabilities	$28.2M
Net Cash	$137.1M
Net Cash By Market Cap	$73.19
Net Cash Growth	-45.84%
Net Debt Equity	$-0.79
Tangible Book Value	$173.7M
Tangible Book Value Per Share	$2.88
WACC	9.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.42
Net Working Capital	$-4.6M
Quick ratio	8.2
Working Capital	$129.5M
Working Capital Turnover	$0.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-77.63%
1Y total return	-5.49%
200-day SMA	3.98
3Y total return	-66.74%
50-day SMA	3.55
50-day SMA vs 200-day SMA	50under200
5Y total return	-0.64%
All Time High	31.91
All Time High Change	-90.29%
All Time High Date	2018-03-05
All Time Low	2.46
All Time Low Change	26.02%
All Time Low Date	2021-10-05
ATR	0.18
Beta	1.27
Beta1y	1.11
Beta2y	1.35
Ch YTD	-21.12
High	3.14
High52	5.55
High52 Date	2025-10-16
High52ch	-44.14%
Low	2.99
Low52	2.88
Low52 Date	2025-08-04
Low52ch	7.49%
Ma50ch	-12.65%
Premarket Change Percent	3.56
Premarket Price	$3.2
Premarket Volume	333
Price vs 200-day SMA	-22.11%
RSI	38.37
RSI Monthly	38.54
RSI Weekly	39.32
Sharpe ratio	0.16x
Sortino ratio	0.34
Tr YTD	-21.12
Tr1m	-16.22%
Tr1w	-2.21%
Tr3m	-23.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	5
Analyst Price Target Top	$19.67
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.52
Earnings Revenue Estimate	4,346,360x
Earnings Revenue Estimate Growth	-16.42x
Operating Income	$-123.9M
Operating margin	-339.6
Price target	$14.89
Price Target Change	$380
Price Target Change Top	$535

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	44,221,039%
Float Percent	73.19%
Shares Insiders	1.15%
Shares Institutions	44.5%
Shares Out	60,421,287
Shares Qo Q	0.95%
Shares Yo Y	1.73%
Short Float	8.08%
Short Ratio	5.93
Short Shares	5.92

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-143.5M
Average Volume	840,579.7x
Bv Per Share	2.88
CAPEX	$-2M
Ch10y	-77.63
Ch1m	-16.22
Ch1w	-2.21
Ch1y	-5.49
Ch3m	-23.27
Ch3y	-66.74
Ch5y	-0.64
Ch6m	-22.5
Change	0.32%
Change From Open	0.98
Close	3.09
Days Gap	-0.65
Depreciation Amortization	3,978,000
Dollar Volume	1,497,340.3
Earnings Date	2026-08-07
Earnings Time	amc
EBIT	$-127.4M
EBITDA	$-123.4M
EPS	$-1.98
F Score	1
FCF	$-129.9M
FCF EV Yield	-258.79x
FCF Per Share	$-2.15
Financing CF	4,066,000
Fiscal Year End	December
Founded	2,013
Income Tax	$121,000
Investing CF	92,346,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-09
Ma150	3.82
Ma150ch	-18.83%
Ma20	3.38
Ma20ch	-8.26%
Net CF	-31,579,000
Next Earnings Date	2026-08-05
Open	3.07
Optionable	Yes
Position In Range	73.33
Ppne	39,427,000
Pre Close	3.09
Price Date	2026-07-24
Ptbv Ratio	1.08
Relative Volume	0.57x
Revenue	36,494,000x
SBC By Revenue	37.27x
Share Based Comp	13,602,000
Tax By Revenue	0.33x
Tr6m	-22.5%
Us State	Massachusetts
Volume	483,013
Z Score	-1.23

Voyager Therapeutics, Inc. (VYGR)

Coverage state: Market snapshot only — no published research

Generate the first VYGR analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · VYGR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VYGR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on VYGR

Frequently asked questions